Atlas Trials

Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia

Clinical trial NCT01254422 · COMPLETED

Trial details

NCT number
NCT01254422
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Dengue FeverDengue Hemorrhagic Fever
Start date
2010-12-02
Primary completion
2012-09-28
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.